Dose-dependent reductions in systolic blood pressure seen in phase 2 dose-ranging study
AHA: Lowering TGs With Pemafibrate Does Not Cut CV Risk in T2DM
In patients with T2DM, hypertriglyceridemia, and low HDL cholesterol levels, the risk for cardiovascular events was not lower with pemafibrate versus placebo
AHA: Strategies Compared for Treating Chronic Limb-Threatening Ischemia
Outcomes better for surgical revascularization versus endovascular therapy for those with single segment of great saphenous vein that could be used for surgery
COVID-19 mRNA Vaccines Tied to Higher Risk for Myocarditis, Pericarditis
Authors say benefits of vaccination still outweigh risks, but some individuals should be aware of their higher risk
AHA: Vaping Tied to Negative Effects on Cardiovascular Function
Increases in BP, heart rate greater; reduction in brachial artery diameter greater; and performance on exercise parameters worse for vapers, smokers compared with controls
AHA: Environmental Exposures Tied to CVD Deaths in the U.S., U.K.
Risk-attributable cardiovascular death rate associated with lead exposure higher in the U.S. than the U.K.; opposite pattern seen between the countries for particulate matter exposure
Subcutaneous ICD Reduces Lead-Related Complications
Trend seen for more inappropriate shocks with S-ICD, but no increase observed in failed appropriate ICD shocks compared with transvenous ICD
Vigorous Physical Activity Linked to Lower Mortality
And, increasing intensity for a given amount of physical activity is associated with reduction in cardiovascular disease
AHA: Heart Disease Death Rates in U.S. Spiked in 2020
Following steady decline from 2010 to 2019, death rates increased in 2020, especially among young adults, non-Hispanic Blacks
Once-Weekly Semaglutide Cuts BMI for Teens With Obesity
Greater reduction in BMI seen for semaglutide plus lifestyle intervention versus lifestyle intervention alone